RE:RE:RE:RE:Divestment of Vaccines to GSKCell culture vacine is the future, as the article indicates, it allows for much greater expedience and flexibility than egg-based vaccine development. This doesn't change what happened in the past; but the future of Novartis using egg-based vaccine and needing Virusmax technology seams somewhat limited now.
I can't say for sure what this means for Microbix and Virusmax, but with speculating starting to run a little wild about Novartis selling the flu vaccine division and other speculations, I thought that bit of information should be put out here to "keep it real"....just like when people here started throwing around Novartis vaccine total revenue numbers and didn't acknowledge the complaint relates specifically to Novartis "Agriflu" product produced in the UK and Italy.
I am a Microbix long and believe we have a great future ahead of us with Lumisort and a possible Virusmax settlement with Novartis, but don't like creating false perceptions or expectations. Ultimately, I believe we have a case for past practices of Agriflu production; but the viability of Virusmax and the Crucible project to expand vaccine production to other countries is somewhat limited now IMO.